Hedvig Björkestrand

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

Hedvig Björkestrand is an author at Amsterdam UMC Location University of Amsterdam specializing in toxicity risk assessment, oncology, and toxicity management.

Publications per year

2018–2018

Publications

The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)

Judi van Diessen, Dirk De Ruysscher, Jan‐Jakob Sonke et al. · Radiotherapy and Oncology · 2018 · 79 citations · Full text

Pharmacy, Oncology, Radiation Oncology +15

Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial

Andreas Hallqvist, Stefan Bergström, Hedvig Björkestrand et al. · Lung Cancer · 2018 · 18 citations

Medicine, Oncology, Chemotherapy +11

1–2 of 2